This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Molecure S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Katarzyna Krysztofiak
Introduction
Katarzyna Krysztofiak is a prominent inventor based in Warsaw, Poland. She has made significant strides in the field of biotechnology, particularly with her work on YKL-40 inhibitors. Her innovative research has the potential to impact therapeutic applications and biosensor technology.
Latest Patents
Katarzyna holds a patent related to YKL-40 inhibitors. This patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. The patent also identifies active compounds as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. She has 1 patent to her name.
Career Highlights
Katarzyna is currently associated with Molecure S.A., where she continues to advance her research in biotechnology. Her work is characterized by a commitment to innovation and the development of new therapeutic strategies.
Collaborations
Katarzyna collaborates with notable colleagues, including Łukasz Krzemiński and Wojciech J Czestkowski. Their combined expertise enhances the research efforts at Molecure S.A.
Conclusion
Katarzyna Krysztofiak's contributions to the field of biotechnology through her patent on YKL-40 inhibitors exemplify her innovative spirit and dedication to advancing medical science. Her work holds promise for future therapeutic applications and biosensor technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile